Loading clinical trials...
Loading clinical trials...
A Double Blind Placebo-controlled Trial of StrataMGT for the Management of Vulvar Lichen Sclerosus Symptoms.
Conditions
Interventions
StrataMGT
Placebo
Locations
3
United States
Centers for Vulvovaginal Disorders, DC
Washington D.C., District of Columbia, United States
Centers for Vulvovaginal Disorders, FL
Tampa, Florida, United States
Centers for Vulvovaginal Disorders, NY
New York, New York, United States
Start Date
October 16, 2024
Primary Completion Date
October 16, 2025
Completion Date
October 16, 2025
Last Updated
November 8, 2024
NCT07363733
NCT04952961
NCT05147129
NCT04148651
NCT03961126
Lead Sponsor
Andrew T. Goldstein, MD
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions